California

CURES: Preparing for the New Duty-to-Consult Requirement

Effective October 2, 2018, California physicians must consult California’s PDMP (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. The California Medical Association recently co-hosted a live CURES webinar with the California Department of Justice and the Medical Board of California regarding this new duty-to-consult requirement.

Learn More
CMA On-Demand Webinar, “CURES 2.0. Navigating the State’s New Prescribing Drug Monitoring Database” (2016)
Learn More
CDPH Resources for Opioid Prescribers (2017)

California Department of Public Health

Learn More
California ACEP Safe Prescribing Guidelines
Learn More
White Paper, “Opioid Analgesics in California: Relieving Pain, Preventung Misuse, Finding Balance.”
Learn More
Be Part of the Solution

Join the AMA today and help us lead the effort to reverse the nation’s opioid epidemic.